Early research (Phase 1)Study completedNCT00124189
What this trial is testing
Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)
Who this might be right for
Chronic Lymphoproliferative Diseases
Geron Corporation 48